Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors

Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors

Abstract Blood pressure measurements form a critical component of adverse event monitoring for tyrosine kinase inhibitors, but might also serve as a biomarker for dose titrations. This study explored the impact of various sources of within‐individual variation on blood pressure readings to improve m...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Maddalena Centanni, Abel Thijs, Ingrid Desar, Mats O. Karlsson, Lena E. Friberg
Định dạng:	Bài viết
Ngôn ngữ:	English
Được phát hành:	Wiley 2023-01-01
Loạt:	Clinical and Translational Science
Truy cập trực tuyến:	https://doi.org/10.1111/cts.13423

Những quyển sách tương tự

Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors
Bằng: Maddalena Centanni, et al.
Được phát hành: (2020-03-01)

Assessment of ibrutinib scheduling on leukocyte, lymph node size and blood pressure dynamics in chronic lymphocytic leukemia through pharmacokinetic‐pharmacodynamic models
Bằng: Eman I. K. Ibrahim, et al.
Được phát hành: (2023-09-01)

Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor
Bằng: Sarah Waliany, MD, MS, et al.
Được phát hành: (2019-09-01)

TYROSINE KINASE INHIBITORS AND INTERFERON
Bằng: Maria Dimou, et al.
Được phát hành: (2014-01-01)

TYROSINE KINASE INHIBITORS AND PREGNANCY
Bằng: Elisabetta Abruzzese, et al.
Được phát hành: (2014-04-01)

Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors Using Dried Blood Microsamples
Bằng: Nick Verougstraete, et al.
Được phát hành: (2022-03-01)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
Bằng: Evan Pisick, et al.
Được phát hành: (2004-01-01)

Inhibition of c-Kit by tyrosine kinase inhibitors
Bằng: Allison Galanis, et al.
Được phát hành: (2015-03-01)

Tyrosine kinase inhibitor Tofacitinib. Safety issues
Bằng: G. V. Lukina, et al.
Được phát hành: (2015-12-01)

Tyrosine Kinase Inhibitors Target B Lymphocytes
Bằng: Nikki Lyn Esnardo Upfold, et al.
Được phát hành: (2023-02-01)

Spheroacanthocytes secondary to novel tyrosine kinase inhibitors
Bằng: Michael Ashby, et al.
Được phát hành: (2020-11-01)

Second-generation inhibitors of Bruton tyrosine kinase
Bằng: Jingjing Wu, et al.
Được phát hành: (2016-09-01)

Targeting tumour microenvironment by tyrosine kinase inhibitor
Bằng: Hor-Yue Tan, et al.
Được phát hành: (2018-02-01)

Mechanisms of resistance to EGFR tyrosine kinase inhibitors
Bằng: Lihua Huang, et al.
Được phát hành: (2015-09-01)

Mechanisms of acquired resistance to tyrosine kinase inhibitors
Bằng: Yi-fan Chen, et al.
Được phát hành: (2011-12-01)

Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease
Bằng: John J. Ryan, MD
Được phát hành: (2016-12-01)

Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
Bằng: Yu Yao, et al.
Được phát hành: (2023-01-01)

The two facets of receptor tyrosine kinase in cardiovascular calcification—can tyrosine kinase inhibitors benefit cardiovascular system?
Bằng: Ainun Nizar Masbuchin, et al.
Được phát hành: (2022-09-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
Bằng: Xu H, et al.
Được phát hành: (2019-07-01)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
Bằng: Huang JT, et al.
Được phát hành: (2022-11-01)

Novel Approaches for Efficient Delivery of Tyrosine Kinase Inhibitors
Bằng: Zahra Moradpour, et al.
Được phát hành: (2019-01-01)

Advances in MET tyrosine kinase inhibitors in gastric cancer
Bằng: Yifan Zhang, et al.
Được phát hành: (2024-06-01)

Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors
Bằng: Jiangnan Liu, et al.
Được phát hành: (2024-03-01)

The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia
Bằng: Obada Ababneh, et al.
Được phát hành: (2022-05-01)

Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa
Bằng: Ahmad Assi, et al.
Được phát hành: (2023-12-01)

Structural Insight and Development of EGFR Tyrosine Kinase Inhibitors
Bằng: Tasia Amelia, et al.
Được phát hành: (2022-01-01)

Flavonoids as receptor tyrosine kinase inhibitors in lung cancer
Bằng: Sareshma Sudhesh Dev, et al.
Được phát hành: (2023-11-01)

Tyrosine kinase inhibitors, ionic currents, and cardiac arrhythmia
Bằng: Chi-Hao Hu, et al.
Được phát hành: (2023-07-01)

Pulmonary hypertension with dasatinib and other tyrosine kinase inhibitors
Bằng: Ashraf El-Dabh, et al.
Được phát hành: (2019-07-01)

Advances in studies of tyrosine kinase inhibitors and their acquired resistance
Bằng: Qinlian Jiao, et al.
Được phát hành: (2018-02-01)

Tyrosine Kinase Inhibitors - Induced Cutaneous Leukocytoclastic Vasculitis
Bằng: Diogo Alpuim Costa, et al.
Được phát hành: (2018-05-01)

Tyrosine Kinase Inhibitor Induced Isolated Pericardial Effusion
Bằng: Vineet Agrawal, et al.
Được phát hành: (2015-02-01)

Acquired Resistance Mechanism for MET Tyrosine Kinase Inhibitor
Bằng: Toshio Fujino, MD, et al.
Được phát hành: (2021-03-01)

Exploring receptor tyrosine kinases-inhibitors in Cancer treatments
Bằng: D. Samuel Metibemu, et al.
Được phát hành: (2019-12-01)

The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance
Bằng: Eliska Ruzickova, et al.
Được phát hành: (2019-10-01)

Small molecule tyrosine kinase inhibitors in pancreatic cancer
Bằng: Sachin Gupta, et al.
Được phát hành: (2008-10-01)

Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
Bằng: Domenico Ribatti
Được phát hành: (2010-04-01)

A Review on Newer Tyrosine Kinase Inhibitors and their Uses
Bằng: NITHU M KUMAR, et al.
Được phát hành: (2018-08-01)

Resistant Mechanism and Treatment Strategy of Tyrosine Kinase Inhibitors
Bằng: Jianbing QIAO, et al.
Được phát hành: (2011-10-01)

Editorial: New Insights on Bruton’s Tyrosine Kinase Inhibitors
Bằng: C. I. Edvard Smith, et al.
Được phát hành: (2021-11-01)